---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076330"
form_type: "8-K"
ticker: null
cik: "0001394319"
company_name: "Tracon Pharmaceuticals, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:46:00.334716+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# TRACON gets Nasdaq delisting notice; CBDO resigns

## Summary
- Nasdaq Hearings Panel determined to delist TCON common stock effective June 13, 2024 for noncompliance with continued listing requirements.
- Trading continues on Nasdaq as of filing date; company expects to move to OTCQB Venture Market under symbol TCON.
- David Lazar voluntarily resigned as Chief Business Development Officer effective June 19, 2024; no disagreement with the company.

## SEC filing metadata
- accession: 0000950170-24-076330
- form_type: 8-K
- cik: 0001394319
- company_name: Tracon Pharmaceuticals, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/0000950170-24-076330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/tcon-20240619.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076330
- JSON: https://secwatch.observer/filing/0000950170-24-076330.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076330.txt

## Key facts
- Executive change
  David Lazar resigned as Chief Business Development Officer at Tracon Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Business Development Officer
  source text: On June 19, 2024, David Lazar notified the Company that he voluntarily resigned from his position as Chief Business Development Officer of the Company, effective June 19, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/0000950170-24-076330-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.